Dear delby: Part of the surgical staging of invasive breast cancer includes an evaluation of the lymph nodes under the arm called axillary lymph nodes. An axillary dissection involves removal of a number of lymph nodes under the arm and these lymph nodes are then evaluated by a pathologist for any evidence of cancer involvement. With a sentinel lymph node biopsy, usually a blue dye and a radioactive tracer are injected into the breast and are expected to travel through the lymphatic channels into the specific lymph nodes draining the breast. The lymph nodes that take up blue dye or the radioactive tracer (as well as any suspicious appearing lymph nodes) are felt to be the most likely to contain cancer if there is any cancer in the lymph nodes. Sentinel lymph nodes are usually evaluated more closely by the pathologist with special stains and may pick up tumor cells which could have been missed with routine staining. If the sentinel lymph nodes are negative for tumor, there is a high likelihood that the remaining lymph nodes that were not removed are also free of cancer. When the sentinel lymph nodes are involved, a full axillary dissection is frequently performed. The total number of lymph nodes involved is a more important prognostic factor than whether the lymph nodes were found with a sentinel lymph node procedure or with a full axillary dissection. One exception may be when a sentinel lymph node has only a few cancerous cells identified only with the special stains but not picked up with routine staining. This type of micrometastasis may have a better prognosis than other lymph node metastases.